These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3902421)

  • 1. Gastric inhibitory polypeptide (GIP) responses after oral glucose ingestion in hyperthyroidism.
    Osei K; Falko JM; O'Dorisio TM; Adam DR
    Diabetes Care; 1985; 8(5):436-9. PubMed ID: 3902421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
    Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
    J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients.
    Osei K; Falko JM; O'Dorisio TM; Adam DR
    Diabetes Care; 1984; 7(5):471-5. PubMed ID: 6389061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
    Crockett SE; Mazzaferri EL; Cataland S
    Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
    Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
    Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GIP on insulin release to intravenous glucose infusion in hyperthyroid rats.
    Müller MK; Hellwig J; Schäfer A; Goebell H; Brown JC
    Horm Metab Res; 1986 Mar; 18(3):163-6. PubMed ID: 3516833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1 and GIP Levels in Patients With Hyperthyroidism: The Effect of Antithyroid Treatment.
    Cira DK; Sari R; Ozdem S; Yilmaz N; Bozkurt S
    Ann Pharmacother; 2017 Aug; 51(8):663-668. PubMed ID: 28452237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
    Ross SA; Dupre J
    Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ingested load on postprandial insulin secretion. Rôle of gastric inhibitory polypeptide (GIP).
    Beck B; Villaume C
    Arch Int Physiol Biochim; 1985 Jun; 93(2):101-6. PubMed ID: 2412503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.
    Crockett SE; Cataland S; Falko JM; Mazzaferri EL
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1098-103. PubMed ID: 932174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin, glucagon and growth hormone responses during glucose, arginine and insulin tolerance tests in children with hyperthyroidism].
    Kato T; Matsuura N; Fujita H; Fujieda K; Nohara Y; Mikami Y; Abe K; Fukushima N
    Nihon Naibunpi Gakkai Zasshi; 1985 Jun; 61(6):665-76. PubMed ID: 3902521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass.
    Sirinek KR; O'Dorisio TM; Hill D; McFee AS
    Surgery; 1986 Oct; 100(4):781-7. PubMed ID: 3532392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gastric inhibitory polypeptide in the response to prolonged parenteral or enteral alimentation in rats.
    Baer AR; Dupre J
    Diabetes; 1985 Nov; 34(11):1108-12. PubMed ID: 3930323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
    Ebert R; Arnold R; Creutzfeldt W
    Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R; Frerichs H; Creutzfeldt W
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Day profiles of glucose dependent insulinotropic polypeptide (GIP) in normal subjects.
    Jones IR; Owens DR; Sarsons DL; Bloom SR
    Horm Metab Res; 1985 Dec; 17(12):660-2. PubMed ID: 3910530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.